Our #WCLC2026 research continues to generate important discussion! Read the article and watch the interview with David R. Gandara, MD, co-author of the study and co-presenter of OncoHost’s poster at WCLC 2026, : onclive.com/view/dr-gandara-… #NSCLC #PrecisionOncology #Proteomics

📍 Headed to the New Orleans Summer Cancer Meeting (NOSCM) this week? Meet Kevin Prophete, our RSD, and learn how our AI-powered PROphet® platform is helping oncologists personalize immunotherapy with confidence. 📅 July 17–19 #NOSCM2026 #OncologyInnovation #PrecisionOncology

What an incredible experience at #EACR2026 in Budapest! A special thank you to Illumina and SomaLogic for making this opportunity possible and for their continued commitment to advancing cancer research through innovation. 🙏 #EACR #PrecisionOncology #Proteomics #CancerResearch

Join our CTO, Dr. Yehonatan Elon, at EACR2026in Budapest as he discusses how advanced proteomic profiling combined with artificial intelligence is driving a new era of personalized cancer care. 📍 Budapest, Hungary 📅 8June 2026 #EACR2026 #EACR #Proteomics #AI #CancerResearch

We’re excited to connect with you at the upcoming #ASCO2026 Annual Meeting in Chicago! 📍 Visit Us at Booth #28148 Stop by to meet our leadership team and explore how our proteomics and AI-powered platform is driving the next era of precision oncology.

Our team is gearing up for ASCO 2026! Stop by our booth #28148 or reach out to [email protected] to set up a meeting! #ASCO2026 #Proteomics #HealthtechLeadership

May is National Cancer Research Month, an initiative led by the American Association for Cancer Research (AACR) to highlight the critical importance of life-saving research for the millions of people worldwide affected by cancer.

🔬 It’s Medical Laboratory Professionals Week! Thank you to our incredible lab professionals - Jim Fuller, Amir Gelman, Michael Hoxie & Macalla Tate! Your dedication to accuracy and excellence is what enables innovation to reach each patient. #LabWeek2026

Our CCO took the stage to present our latest poster, highlighting the role of biological aging in predicting #immunotherapy outcomes. Take a closer look at the science driving the future of personalized cancer care. #AACR26 #PrecisionOncology #CancerResearch #Proteomics

Attending AACR? Don’t miss our poster presentation: “Proteomic aging biomarkers predict survival in immunotherapy-treated tumors.” 🗓 Monday, April 20, 2026 🕘 9:00 AM – 12:00 PM (PDT) Stop by to explore how proteomic insights are shaping the future of immunotherapy outcomes.

We're proud to announce the acceptance of our abstract for presentation at the 2026 American Association for Cancer Research (AACR) Annual Meeting taking place next week in San Diego! Read our news release here: prn.to/4cpwg9R

Our team is heading to #AACR2026 this weekend! ✈️🔬 We’re looking forward to connecting with the global oncology community, exchanging insights, and driving the future of precision medicine through innovative biomarker-driven solutions. See you there!

Thank you @MLO for spotlighting our recent publication in the JPBA! This study introduces a validated computational method to harmonize serum and plasma proteomic datasets, overcoming longstanding analytical barriers. Read the coverage 👇 bit.ly/4dVSnqR

🏆We’re proud to share that OncoHost has been named a winner in the 2026 Artificial Intelligence Excellence Awards by the Business Intelligence Group, taking top recognition in the Health category! prn.to/4d2Qfxe #AIExcellence #PrecisionMedicine #HealthcareInnovation

🚀 Redefining Precision Oncology with PROphet®, our flagship host-response profiling technology, designed to predict therapeutic outcomes with unprecedented accuracy — giving physicians a powerful edge in managing complex cancers. 👉 bit.ly/3NPyrrN

Thank you MedPath for highlighting our latest research! The study introduces a validated computational framework that harmonizes serum and plasma proteomic datasets - helping overcome a long-standing barrier in biomarker research. bit.ly/4s4SoNn

Have you read the latest peer-reviewed review on emerging predictive biomarkers for immunotherapy sensitivity in #NSCLC? 📖 Scan the QR code below or access the article here: 👉 bit.ly/4rW4cS5 #PrecisionOncology #Immunotherapy #Biomarkers

PROphet® is featured in a recent peer-reviewed review spotlighting next-generation predictive biomarkers shaping immunotherapy decision-making in #NSCLC! 👉 dovepress.com/emerging-predi… #PrecisionOncology #Immunotherapy #Biomarkers

We’re proud to share that PROphet® has been recognized in the latest peer-reviewed review on emerging predictive biomarkers of immunotherapy sensitivity in patients with NSCLC published by DovePress! 👉 dovepress.com/emerging-predi… #PrecisionOncology #Immunotherapy #Biomarkers

We are proud to announce the publication of our latest study in JPBA! We are grateful to our collaborators at NCI, Yale Medicine, Heidelberg University Hospital, and ions.bio for their partnership. tinyurl.com/ks3ww6hb doi.org/10.1016/j.jpba.2026.…